| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
96,594 |
87,170 |
$1.16M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
70,946 |
63,076 |
$688K |
| 99215 |
Prolong outpt/office vis |
10,114 |
9,652 |
$135K |
| 90688 |
|
6,567 |
6,315 |
$125K |
| 36415 |
Collection of venous blood by venipuncture |
52,186 |
49,755 |
$106K |
| 0064A |
|
1,477 |
1,420 |
$75K |
| 90686 |
|
4,073 |
3,131 |
$70K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
6,650 |
6,367 |
$64K |
| 0011A |
|
1,668 |
1,666 |
$64K |
| 0012A |
|
1,491 |
1,487 |
$58K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
12,836 |
11,768 |
$57K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,663 |
4,498 |
$51K |
| 90670 |
|
2,278 |
1,806 |
$46K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,291 |
1,257 |
$37K |
| 99173 |
|
12,815 |
12,316 |
$34K |
| 90651 |
|
1,074 |
896 |
$31K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,387 |
2,264 |
$31K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
730 |
684 |
$29K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,623 |
4,400 |
$26K |
| 91320 |
|
259 |
256 |
$25K |
| 90723 |
|
968 |
931 |
$22K |
| 96127 |
|
2,981 |
2,857 |
$22K |
| 90648 |
|
961 |
912 |
$21K |
| 0134A |
|
585 |
523 |
$19K |
| 90480 |
|
546 |
536 |
$19K |
| 90633 |
|
758 |
736 |
$17K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
3,819 |
3,420 |
$16K |
| 0001A |
|
398 |
392 |
$16K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,776 |
3,615 |
$15K |
| 90734 |
|
644 |
636 |
$15K |
| 90658 |
|
784 |
776 |
$15K |
| 90710 |
|
624 |
612 |
$14K |
| 36416 |
|
2,898 |
2,590 |
$13K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
577 |
533 |
$13K |
| 90662 |
|
491 |
458 |
$13K |
| 0124A |
|
403 |
357 |
$12K |
| 0004A |
|
221 |
218 |
$12K |
| 0071A |
|
191 |
188 |
$12K |
| 90715 |
|
400 |
386 |
$10K |
| 90697 |
|
448 |
429 |
$10K |
| 0002A |
|
229 |
221 |
$9K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,313 |
1,229 |
$9K |
| 90677 |
|
331 |
254 |
$9K |
| 0054A |
|
214 |
193 |
$8K |
| 99205 |
Prolong outpt/office vis |
329 |
316 |
$8K |
| 0072A |
|
114 |
114 |
$8K |
| 90685 |
|
401 |
348 |
$8K |
| 92551 |
|
13,003 |
12,438 |
$7K |
| 90681 |
|
321 |
308 |
$7K |
| W7000 |
|
1,299 |
1,240 |
$7K |
| 90756 |
|
274 |
273 |
$6K |
| 90647 |
|
267 |
265 |
$6K |
| 91322 |
|
33 |
33 |
$5K |
| 90620 |
|
229 |
199 |
$5K |
| 90696 |
|
133 |
131 |
$3K |
| 90694 |
|
132 |
107 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
484 |
430 |
$3K |
| 90656 |
|
104 |
104 |
$2K |
| 88150 |
|
934 |
883 |
$2K |
| 90671 |
|
136 |
118 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,448 |
1,367 |
$2K |
| 90700 |
|
87 |
80 |
$2K |
| 90750 |
|
12 |
12 |
$2K |
| 90653 |
|
48 |
47 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
67 |
65 |
$1K |
| 90746 |
|
12 |
12 |
$837.06 |
| 90619 |
|
34 |
34 |
$791.52 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
58 |
55 |
$667.64 |
| 96161 |
|
233 |
212 |
$646.02 |
| 84702 |
|
69 |
68 |
$636.32 |
| 99381 |
|
13 |
13 |
$625.00 |
| Q2037 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) |
66 |
66 |
$618.40 |
| 87807 |
|
64 |
64 |
$296.64 |
| 90657 |
|
12 |
12 |
$279.36 |
| 93000 |
|
43 |
42 |
$112.88 |
| 94010 |
|
19 |
19 |
$59.92 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
664 |
624 |
$46.47 |
| 91313 |
|
452 |
424 |
$0.07 |
| 91312 |
|
293 |
274 |
$0.02 |
| 91300 |
|
1,471 |
1,383 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
662 |
642 |
$0.00 |
| 91301 |
|
3,781 |
3,713 |
$0.00 |
| 91305 |
|
282 |
282 |
$0.00 |
| 91306 |
|
1,173 |
1,165 |
$0.00 |
| 91307 |
|
454 |
418 |
$0.00 |
| H0001 |
Alcohol and/or drug assessment |
12 |
12 |
$0.00 |